B-cell acute lymphoblastic leukemia
GPTKB entity
Properties (54)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:healthcare_organization
|
| gptkbp:advertising |
gptkb:Leukemia_and_Lymphoma_Society
Light the Night |
| gptkbp:associatedWith |
gptkb:Klinefelter_syndrome
Down syndrome neurofibromatosis |
| gptkbp:barrelLength |
improving over time
varies by risk group |
| gptkbp:clinicalTrials |
ASCO guidelines
ongoing trials completed trials WHO classification NCCN_guidelines |
| gptkbp:commonName |
children
young adults |
| gptkbp:community_service |
BCR-ABL fusion gene
TP53 mutations ETV6-RUNX1 fusion gene IKZF1 deletions NOTCH1 mutations |
| gptkbp:diseaseResistance |
blood tests
varies by age bone marrow biopsy varies by treatment response |
| gptkbp:events |
September
|
| https://www.w3.org/2000/01/rdf-schema#label |
B-cell acute lymphoblastic leukemia
|
| gptkbp:impact |
B cells
targeted therapies radiation therapy CAR T-cell therapy chemotherapy relapse remission stem cell transplant clinical trials for new drugs |
| gptkbp:number_of_stages |
early stage
advanced stage |
| gptkbp:relatedPatent |
infections
organ damage bleeding problems |
| gptkbp:researchFocus |
genetic mutations
immunotherapy new therapies |
| gptkbp:riskManagement |
genetic disorders
certain chemicals exposure to radiation |
| gptkbp:supports |
online forums
patient advocacy organizations local support groups |
| gptkbp:symptoms |
fatigue
fever pale skin easy bruising |
| gptkbp:typeOf |
leukemia
|